drugset / Trial / NCT04501354

Evaluation of Clinical and Bone Density Improvement After Implantation of Allogenic Mesenchymal Stem Cell From Umbilical Cord on Osteoporosis Patients

NCT04501354

Phase 2 Unknown 5 enrolled Ahmad Jabir Rahyussalim
NaSingle-groupOpen-labelTreatment

Summary

This study will assess the effectiveness of the allogeneic mesenchymal cell from umbilical cord in improving the quality and quantity of spinal density of osteoporosis patients proven by the results of Bone Mass Density (BMD) examination compared to baseline and evaluate improvement of quality of pain with visual analog scale (VAS).

Timeline

Start
2020-08
Primary completion
2020-12
Completion
2020-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Mesenchymal stem cell Cell therapy

Indications